New muco-adhesive patch may help treat oral disorders
A newly developed time-released muco-adhesive patch for treating oral health conditions, including the widespread condition of dry mouth (xerostomia), has been shown to be more effective than a leading...
View ArticleMeda acquires Pyralvex, Spasmonal and Waxsol from Norgine
Meda has acquired three well established OTC products from Norgine, a Dutch pharma company. The products are Pyralvex (relief of pain associated with e.g. aphthous ulcers), Spasmonal (treatment of for...
View ArticleAmlexanox also reverses obesity, diabetes and fatty liver in mice
Researchers at the University of Michigan's Life Sciences Institute have found that amlexanox, an off-patent drug currently prescribed for the treatment of asthma and other uses, also reverses obesity,...
View ArticleResearch finds number of links between dental health and overall health
If the eyes are the windows to your soul, then your mouth is the gateway to your overall health. Research has found a surprising number of links between the state of your dental health and your overall...
View ArticleResearchers reveal how metabolic system breaks down in obesity
Researchers at University of Michigan have illuminated an aspect of how the metabolic system breaks down in obesity. The findings provide additional evidence that a drug entering clinical trials at the...
View ArticleAccess provides update on new formulation of anti-inflammatory drug amlexanox
ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) provided an update on a new formulation of the anti-inflammatory drug amlexanox, called LexaGard™, for the treatment of inflammatory and ulcerative conditions...
View ArticleOral health: The gateway to your overall health
If the eyes are the windows to your soul, then your mouth is the gateway to your overall health. Research has found a surprising number of links between the state of your oral health and your overall...
View ArticleAccess Pharmaceuticals enters into exclusive license agreement with Norgine
ACCESS PHARMACEUTICALS, INC., an emerging biopharmaceutical company, today announced that it had entered into an exclusive license agreement with Norgine B.V., a leading independent European specialty...
View ArticleResearchers develop new formulations for topical treatments of oral mucosal...
On June 24, 2016, at the 94th General Session & Exhibition of the International Association for Dental Research, researcher W. Peter Holbrook, University of Iceland, will present a study titled...
View ArticleResearch sheds new light on reasons behind recurrent aphthous stomatitis
A burning pain sensation - and treatments that do not work. This is what daily life is like for many of those who suffer from recurrent aphthous stomatitis. Research from the Sahlgrenska Academy now...
View Article
